Single Administration of a Sustained-Release Formulation of KB-R7785 Inhibits Tympanic Membrane Regeneration in an Animal Model.
J Int Adv Otol. 2016 Dec;12(3):237-240. doi: 10.5152/iao.2016.3124.
J Int Adv Otol. 2016.
PMID: 28031154